Advocacy

Thoracic Society activity update 

TSANZ Strategic Plan 2021-26. Goal 5.1 - The TSANZ will advocate both independently and in partnership to achieve improved respiratory health and research outcomes. Our advocacy is evidence-based, independent and robust. Advocacy is a key part of what we do in Australia and New Zealand.

The Thoracic Society of Australia and New Zealand (TSANZ) is an active leader in advocating for lung health. We provide evidence-based policy and advice in the field of respiratory medicine and related areas. Our purpose is to promote the highest standards of patient care; develop and apply knowledge about respiratory health and disease and promote the highest quality air standards. We will collaborate with all national organisations whose objects are to improve the wellbeing of individuals affected by respiratory conditions and to promote better lung health for the community.

In recent years we have provided solicited and open consultation advice to the Australian and New Zealand federal governments, state and territory government bodies, organisations, and agencies.  We remain committed to improving the lung health for all Australians and New Zealanders.

The Society participates reactive policy pieces, as well as proactive advocacy projects which are driven by our membership and our aim to improve the standard and care of lung health. The content of our submissions is data-driven and underpinned by member involvement. Recent submissions are detailed below in reverse chronological order. Our submissions to enquiries which are now closed have been linked in the tables below. If you are interested in a submission mentioned below that is not hyperlinked, please contact the office for more information.

tsanzoffice@thoracic.org.au or +61 2 9222 62006

List of Submissions

2022 Submissions

Date     

Name of Consultation

Agency

Status

28-Mar-22

Proposal for a priority review pathway for biologicals

TGA

Complete

24-Mar-22 

National Tobacco Strategy

Australian Department of Health

Complete - submission

18-Mar-22

Proposal to widen access to influenza vaccine

PHARMAC Complete - submission
16-Mar-22 Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes. Respirology Published in Respirology
11-Mar-22 Letter regarding to Prime Minister and Expenditure Review Committee regarding Urgent need for funding of the National Lung Cancer Screening Program in the 2022-2023 budget Australian Federal Government Letter sent
04-Mar-22 The Australian Cancer Plan 2022-2023 Cancer Australia Complete - submission
02-Mar-22 Consultation on COVID-19 Treatments PHARMAC Complete - submission
02-Mar-22 National Medicines Policy Consultation Australian Department of Health Complete - submission
16-Feb-22 Statement by Respiratory Physicians - Supporting medical professionals to improve the diagnosis and management of workers affected by silicosis RACP Complete

11-Feb-22 

MSAC 1699 - National Lung Cancer Screening

MSAC

Complete

28-Jan-22 

Proposal to fund treatments for cancer and asthma

PHARMAC

Complete - submission

 

 

 

 

 

 

 

 

 

 

--

2021 Submissions

Date     

Name of Consultation

Agency

Status

21-Dec-21 National One Stop Shop Australian Commission on Safety and Quality in Health Care submission
16-Dec-21 NHMRC Guidelines for Guidelines Consultation National Health and Medical Research Council submission
12-Nov-21 Occupational Health Risks in the Queensland Resources Industry Consultation Queensland Government submission
18-Oct-21 National Medicines Policy Review Australian Department of Health submission
16-Oct-21 MSAC Application 1689 Medical Services Advisory Committee Complete
08-Oct-21 Health Coalition Aotearoa New Zealand Government submission
05-Oct-21 Australian Medical Research and Innovation Strategy and Priorities Consultation Medical Research Future Fund submission
24-Aug-21 RACP: Palliative Care Australia Consultation Royal Australasian College of Physicians submission

 2-Jun-21

TGA: TGO110 Guidance

Therapeutic Goods Administration

Complete

31-May-21 

NZ Consultation on Proposal for a SmokeFree Aoteroa 2025 Action Plan

NZ Ministry of Health

Complete

21-May-21 

Draft MBS Item: Nicotine Cessation

Australian Department of Health

Complete

7-May-21 

NSW Clean Air Strategy

NSW Government

Complete - submission

6-May-21 

National Guidelines for Doctors Managing Workers Exposed to Respirable Crystalline

Australian Department of Health

Feedback sent to Department

28-Apr-21 

Joint Letter with ACTU regarding National Dust Disease Taskforce

Australian Government

Complete - submission

26-Apr-21 

MSAC Application 1646

Medical Services Advisory Committee

Complete

26-Apr-21 

MSAC Application 1660

Medical Services Advisory Committee

Complete

19-Apr-21 

National Preventive Health Strategy

Australian Government

Complete - submission

15-Apr-21 

NZ Consultation on SmokeFree Environment Regulatory Products Act

NZ Ministry of Health

Complete - submission

2-Apr-21 

Victorian Inquiry into Health Impacts of Air Pollution in Australia

Victorian Government

Complete - submission

31-Mar-21 

Do Guidelines Make a Difference? NHMRC's National Consultation on Guideline Impact

National Health and Medical Research Council

Complete - submission

31-Mar-21 

TGA Consultation on Vaping Nicotine TGO110

Therapeutic Goods Administration

Complete

21-Jan-21 

Lung Cancer Screening Enquiry

Cancer Australia

Complete - submission

 

 

 

 

 

 

 

 

 




 

 

 

 

 

--

 

2020 Submissions

Date

Name of Consultation

Agency

Status

21-Dec-20 

Overnight Oximetry

Medicare Schedule Advisory Committee

Consultation ongoing

18-Dec-20 

Clinical Thoracic Indicators

Australian Council on Health Standards

Consultation ongoing

11-Nov-20 

National Dust Disease Taskforce Consultation Phase 2

Department of Health

Complete - submission

30-Oct-20 

Interim Decision to amend the Nicotine Entry in the Poisons Standard

Therapeutic Goods Administration

Complete - submission

16-Oct-20 

Application 1634 - targeted public consultation - Comprehensive genomic profiling of non-small cell lung cancer tumour tissue specimens using next generation sequencing assays

Medicare Schedule Advisory Committee

Complete

28-Sep-20 

National Preventive Health Strategy

Australian Government

Complete - submission

27-Jul-20 

Health Coalition's Prevention Brief

Health Coalition NZ

Complete - submission

2-Jun-20 

COVID Inquiry Letter

Committee Secretary, Department of the Senate

Complete

23-Apr-20 

Advanced Training in Paediatrics Respiratory Medicine

Department of Health and Human Services

Ongoing

10-Mar-20 

New MBS item number for Alpha-1-antitrypsin genotyping

Medicare Schedule Advisory Committee

Complete

18-Feb-20 

Health impacts of exposure to poor levels of air quality resulting from bushfires and drought

NSW Legislative Council

Complete – joint submission with Lung Foundation Australia

17-Feb-20 

Changes to Medical CPD

Medical Board of Australia

Complete

17-Feb-20 

Lung Cancer Screening enquiry

Cancer Australia

Complete – submission

21-Jan-20 

Request for Information on Research Investment

Lung Foundation Australia

Complete

17-Jan-20 

Consultation on Mepolizumab Final

PHARMAC

Complete – submission

 

 

2019 Submissions

Date

Name of Consultation

Agency

Status

19-Dec-19 

Australian Engineered Stone Advisory Group - Silicosis

Australian Competition and Consumer Commission

Complete - submission

10-Dec-19 

MBS Policy and Specialist Services Branch item review Dec 2019

Department of Health

Complete

27-Nov-19 

Vaping letter to Associate Minister of Health

Ministry of Health NZ

Complete - submission

28-Oct-19 

Joint TSANZ, AFOEM and RACP Submission to the National Dust Disease Taskforce Consultation Paper

Department of Health

Complete - submission

30-Sep-19 

Assessing Fitness for work in coal mining and doctor engagement

Department of Natural Resources, Mines, and Energy QLD

Complete

29-Aug-19 

Health Legislation Amendment and Repeal Bill 2019

Georgie Crozier MP

Complete - submission

21-Aug-19 

PHARMAC Consultation on the proposal for funding of oncology, multiple sclerosis and respiratory treatments

PHARMAC (Pharmaceutical Management Agency)

Complete

20-Aug-19 

Mobile service for Queensland Mine Workers

Department of Natural Resources, Mines, and Energy QLD

Complete

14-Aug-19 

Peripheral Venous Access Clinical Care Standard

Australian Commission on Safety and Quality in Health Care

Complete

14-Aug-19 

Engineered Stone Position Statement

Royal Australian and New Zealand College of Radiologists

Complete - submission

1-Jul-19 

NSW Dust Disease Scheme

Dust Diseases Authority

Complete - submission

1-Jul-19 

Review of MBS Nov1 2018 Changes

Department of Health

Complete - submission

 

 

2018 Submissions

Date

Name of Consultation

Agency

Status

Nov-18 

Review of Dust Diseases Scheme

NSW Government

Complete - submission

Oct-18 

Sleep Parliamentary Inquiry

Australian Government

Complete - submission

Oct-18 

Notifiable Dust Lung Disease Consultation

Queensland Health

Complete - submission

Oct-18 

Letter of Endorsement to RACP Position Statement and Evidence Review Action to prevent obesity and reduce its impact across the life course

RACP

Complete - submission

Sep-18 

Nintedanib, Pirfenidone, and Tiotropium bromide consultation

PHARMAC

Complete

Aug-18 

Ministerial Brief on Lung Conditions in Australia

Australian Government

Complete - submission

Aug-18 

MSAC 1540 Targeted consultation regarding vigilance testing

MSAC

Complete

Jul-18 

Omalizumab consultation

PHARMAC

Complete

May-18 

Draft descriptors for Thoracic Medicine - Respiratory and Sleep Studies

MBS

Complete

May-18 

Draft Model Scope of Clinical Practice

NSW Health

Complete - submission

Apr-18 

RACP Working Party on Medical Assistance in Dying

RACP

Complete

Mar-18 

RACP Policy paper on e-cigarettes

RACP

Complete - submission

Feb-18 

PHARMAC Montelukast consultation

PHARMAC

Complete

Feb-18 

PBAC asthma monoclonals

PBAC

Complete

Feb-18 

MBS Review items for thoracic medicine

MBS

Complete

Feb-18 

MSAC 1530 Targeted consultation regarding alpha1-proteinase inhibitors

MSAC

Complete

 

2017 Submissions

Date

Name of Consultation

Agency

Status

Dec-17

Biosimilar Uptake Drivers Implementation

 

Pharmaceutical Benefits Advisory Council

Complete

Aug-17

Review of the Dust Diseases and Lifetime Care and Support Schemes

NSW Legislative Council

Complete

Jul-17

Department of Mines spirometry review and standards

Queensland Government

Complete

Jul-17

NSW Tobacco Strategy 2018-2022 feedback

NSW Government

Complete

Jul-17

NHMRC Public consultation on “A Framework for NHMRC Assessment and Funding of Clinical Trials and Cohort Studies”

National Health and Medical Research Council

Complete

Jul-17

Inquiry into the Use of Electronic Cigarettes and Personal Vaporisers in Australia

Australian Government

Complete

May-17

Response to the Draft Report for the Post-market Review of COPD Medicines

Pharmaceutical Benefits Advisory Council

Complete

Apr-17

MBS Review

 

Department of Health

Complete

Apr-17

RACP Training Network Principles Survey

 

Royal Australasian College of Physicians

Complete

Mar-17

Post-market Review of Pulmonary Arterial Hypertension (PAH) Medicines3 government hearings

Pharmaceutical Benefits Advisory Council

Complete

Mar-17

Committee Select Committee into Funding for Research into Cancers with Low Survival Rates

Australian Government

Complete

Feb-17

Tobramycin inhalation review

Pharmaceutical Benefits Advisory Council

Complete